Quarterly report · Q2
4599.TEDINET S100QCYP
Period2022-08-01 → 2023-01-31
Filed2023-03-09
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 43
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Operating income | −¥1.0bn | 2022-08-01 → 2023-01-31 | Standalone | Operating income |
| Operating income | −¥1.0bn | 2021-08-01 → 2022-01-31 | Standalone | Operating income |
| Ordinary income | −¥1.0bn | 2022-08-01 → 2023-01-31 | Standalone | Ordinary income |
| Ordinary income | −¥2.0bn | 2021-08-01 → 2022-07-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥1.0bn | 2021-08-01 → 2022-01-31 | Standalone | Ordinary income |
| Profit before tax | −¥1.0bn | 2022-08-01 → 2023-01-31 | Standalone | Income before income taxes |
| Profit before tax | −¥1.0bn | 2021-08-01 → 2022-01-31 | Standalone | Income before income taxes |
| Net income | −¥1.0bn | 2022-08-01 → 2023-01-31 | Standalone | Profit loss |
| Net income | −¥1.9bn | 2021-08-01 → 2022-07-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.0bn | 2021-08-01 → 2022-01-31 | Standalone | Profit loss |
| Total assets | ¥9.1bn | at 2023-01-31 | Standalone | Assets |
| Total assets | ¥9.6bn | at 2022-07-31 | Standalone | Assets |
| Total assets | ¥10.3bn | at 2022-01-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥211m | at 2023-01-31 | Standalone | Liabilities |
| Total liabilities | ¥192m | at 2022-07-31 | Standalone | Liabilities |
| Net assets / equity | ¥8.9bn | at 2023-01-31 | Standalone | Net assets |
| Net assets / equity | ¥9.4bn | at 2022-07-31 | Standalone | Net assets |
| Net assets / equity | ¥10.1bn | at 2022-01-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.4bn | at 2023-01-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥8.9bn | at 2022-07-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥8.4bn | at 2023-01-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2022-07-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥9.7bn | at 2022-01-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥10.2bn | at 2021-07-31d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥569m | 2022-08-01 → 2023-01-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.4bn | 2021-08-01 → 2022-07-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥545m | 2021-08-01 → 2022-01-31 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥330,000 | 2021-08-01 → 2022-07-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥551,000 | 2021-08-01 → 2022-01-31 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥99m | 2022-08-01 → 2023-01-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥113m | 2021-08-01 → 2022-07-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥93m | 2021-08-01 → 2022-01-31 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-17.03 | 2022-08-01 → 2023-01-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.41 | 2022-11-01 → 2023-01-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-32.92 | 2021-08-01 → 2022-07-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-17.07 | 2021-08-01 → 2022-01-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.75 | 2021-11-01 → 2022-01-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 86.3% | at 2023-01-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 88.7% | at 2022-07-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.4% | at 2022-01-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 59,995,600 | at 2023-01-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 59,402,400 | at 2022-07-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 59,312,700 | at 2022-01-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 371
| Item | Context | Value | Unit |
|---|---|---|---|
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYTDDuration | Text · Plus | |
| Note on independent audit financial information | CurrentYTDDuration | Text · Plus | |
| Description of fact that consolidated financial statements have not been prepared financial information | CurrentYTDDuration | Original text (Japanese)当社は、子会社がありませんので、四半期連結財務諸表を作成しておりません。 | |
| Quarterly balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding research and development expenses (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1YTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration_NonConsolidatedMember | Text · Plus | |
| Notes segment information etc quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | CurrentYTDDuration_NonConsolidatedMember | Original text (Japanese)当社は再生誘導医薬事業の単一セグメントであるため、セグメント別の業績記載を省略しております。 | |
| Notes revenue recognition quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |